Evgeniia Borisova Ken Nishimura Yuri An Miho Takami Jingyue Li Dan Song Mami Matsuo-Takasaki Dorian Luijkx Shiho Aizawa Akihiro Kuno Eiji Sugihara Taka-Aki Sato Fumiaki Yumoto Tohru Terada Koji Hisatake Yohei Hayashi
iScience 25(1) 103525-103525 2022年1月 [査読有り]
Non-genetically modified somatic cells can only be inefficiently and stochastically reprogrammed to pluripotency by exogenous expression of reprogramming factors. Low competence of natural reprogramming factors may prevent the majority of cells to...
Journal of human genetics 67(6) 363-368 2022年1月 [査読有り]
Structural analysis of small supernumerary marker chromosomes (sSMCs) has revealed that many have complex structures. Structural analysis of sSMCs by whole genome sequencing using short-read sequencers is challenging however because most present w...
Shiho Aizawa Ken Nishimura Gonzalo Seminario Mondejar Arun Kumar Phuong Linh Bui Yen Thi Hai Tran Akihiro Kuno Masafumi Muratani Shin Kobayashi Tsukasa Nabekura Akira Shibuya Eiji Sugihara Taka-Aki Sato Aya Fukuda Yohei Hayashi Koji Hisatake
Stem cell reports 17(1) 53-67 2021年11月 [査読有り]
Reprogramming of murine female somatic cells to induced pluripotent stem cells (iPSCs) is accompanied by X chromosome reactivation (XCR), by which the inactive X chromosome (Xi) in female somatic cells becomes reactivated. However, how Xi initiate...
Yoichi Fujii Yusuke Sato Hiromichi Suzuki Nobuyuki Kakiuchi Tetsuichi Yoshizato Andrew T Lenis Shigekatsu Maekawa Akira Yokoyama Yasuhide Takeuchi Yoshikage Inoue Yotaro Ochi Yusuke Shiozawa Kosuke Aoki Kenichi Yoshida Keisuke Kataoka Masahiro M Nakagawa Yasuhito Nannya Hideki Makishima Jimpei Miyakawa Taketo Kawai Teppei Morikawa Yuichi Shiraishi Kenichi Chiba Hiroko Tanaka Genta Nagae Masashi Sanada Eiji Sugihara Taka-Aki Sato Tohru Nakagawa Masashi Fukayama Tetsuo Ushiku Hiroyuki Aburatani Satoru Miyano Jonathan A Coleman Yukio Homma David B Solit Haruki Kume Seishi Ogawa
Cancer cell 39(6) 793-809 2021年6月 [査読有り]
Upper urinary tract urothelial carcinoma (UTUC) is one of the common urothelial cancers. Its molecular pathogenesis, however, is poorly understood, with no useful biomarkers available for accurate diagnosis and molecular classification. Through an...
お知らせ・マニュアル
研究推進本部